COLLIGNON MEDICAL IMAGING: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
COLLIGNON MEDICAL IMAGING
Largest movements
- Current investments +€120,000
new in 2025: €120,000
- Cash +€18,385
up €18,385 (+13.9%), from €132,158 to €150,543
mainly Net result for the year (+€175,700) and Tax, wage and social debts (+€6,446)
- Receivables within one year +€15,994
up €15,994 (+107%), from €14,905 to €30,900
- Profit (loss) carried forward +€175,700
up €175,700 (+94.2%), from €186,455 to €362,155
- Other debts -€27,735
down €27,735 (-99.3%), from €27,940 to €206
- Tax, wage and social debts +€6,446
up €6,446 (+53.7%), from €12,000 to €18,446
- Gross operating margin -€15,076
down €15,076 (-6.1%), from €246,155 to €231,079
- Taxes -€3,054
down €3,054 (-5.4%), from €57,000 to €53,946
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €229,395 | €383,899 | +€154,504 | +67.4% |
| Fixed assets | 21/28 | €2,331 | €2,456 | +€124 | +5.3% |
| Tangible fixed assets | 22/27 | €2,331 | €2,456 | +€124 | +5.3% |
| Furniture and vehicles | 24 | €2,331 | €2,456 | +€124 | +5.3% |
| Current assets | 29/58 | €227,063 | €381,443 | +€154,379 | +68.0% |
| Amounts receivable after more than one year | 29 | €80,000 | €80,000 | = | 0.0% |
| Other amounts receivable | 291 | €80,000 | €80,000 | = | 0.0% |
| Amounts receivable within one year | 40/41 | €14,905 | €30,900 | +€15,994 | +107% |
| Trade receivables | 40 | €14,905 | €30,900 | +€15,994 | +107% |
| Current investments | 50/53 | - | €120,000 | +€120,000 | |
| Cash at bank and in hand | 54/58 | €132,158 | €150,543 | +€18,385 | +13.9% |
| Total equity and liabilities | 10/49 | €229,395 | €383,899 | +€154,504 | +67.4% |
| Equity | 10/15 | €189,455 | €365,155 | +€175,700 | +92.7% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €186,455 | €362,155 | +€175,700 | +94.2% |
| Amounts payable | 17/49 | €39,940 | €18,744 | -€21,196 | -53.1% |
| Amounts payable within one year | 42/48 | €39,940 | €18,744 | -€21,196 | -53.1% |
| Trade debts | 44 | - | €92 | +€92 | |
| Suppliers | 440/4 | - | €92 | +€92 | |
| Taxes, remuneration and social security | 45 | €12,000 | €18,446 | +€6,446 | +53.7% |
| Taxes | 450/3 | €12,000 | €18,446 | +€6,446 | +53.7% |
| Other amounts payable | 47/48 | €27,940 | €206 | -€27,735 | -99.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €775 | €1,454 | +€678 | +87.4% |
| Other operating charges | 640/8 | €1,900 | - | -€1,900 | |
| Gross operating margin | 9900 | €246,155 | €231,079 | -€15,076 | -6.1% |
| Operating profit (loss) | 9901 | €243,480 | €229,626 | -€13,854 | -5.7% |
| Financial income | 75/76B | - | €119 | +€119 | |
| Recurring financial income | 75 | - | €119 | +€119 | |
| Financial charges | 65/66B | €25 | €98 | +€73 | +294% |
| Recurring financial charges | 65 | €25 | €98 | +€73 | +294% |
| Profit (loss) for the period before taxes | 9903 | €243,455 | €229,646 | -€13,808 | -5.7% |
| Income taxes | 67/77 | €57,000 | €53,946 | -€3,054 | -5.4% |
| Profit (loss) for the period | 9904 | €186,455 | €175,700 | -€10,755 | -5.8% |
| Profit (loss) for the period to be appropriated | 9905 | €186,455 | €175,700 | -€10,755 | -5.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 23 October 2026 via checked.be.